Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in the human colon carcinoma cell line LS180

Phytotherapy Research

Volumn 21, Issue 3, 2007, Pages 239-244

  Brandin, Helena ^a   Viitanen, Eila ^a   Myrberg, Olle ^a   Arvidsson, Ann Kristin ^a  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Cytochrome P450 enzymes; Herbal medicinal products; Induction; Real time quantitative polymerase chain reaction

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; ALOE VERA BARBADENSIS EXTRACT; ALPENKRAFT; ALPINIA GALANGA EXTRACT; ARCTOSTAPHYLOS UVA URSI EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; BIO STRATH; CERNITOL; CHRYSANTHEMUM EXTRACT; CITROSEED; COLDIZIN; CRATAEGUS EXTRACT; CYNARAMIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; EFALEX; ELEUTEROCOCCUS SENTICOSUS EXTRACT; FISH OIL; GENTIANA LUTEA EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GOU GI ZI; HERBACEOUS AGENT; HUANG QI; JIN YIN HUA; LINFROOLJA; LINSEED OIL; LITOZIN; LONICERA JAPONICA EXTRACT; LYCIUM BARBARUM EXTRACT; LYPRINOL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PERNA CANALICULUS EXTRACT; PLANT EXTRACT; POLLEN EXTRACT; RHODIOLA ROSEA EXTRACT; RYSKROT; SABAL EXTRACT; SABAMIN; SALVIA OFFICINALIS EXTRACT; SCHISANDRA CHINENSIS EXTRACT; SHAN ZHA; SINOVA; SOLIDAGO VIRGAUREA EXTRACT; SOLIDAMIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVA E; VENASTAT; VILD JU HUA; WU WEI ZI; ZINAXIN;

AESCULUS HIPPOCASTANUM; ALOE VERA; ARCTOSTAPHYLOS UVA URSI; ARTICLE; ASTRAGALUS MEMBRANACEUS; CANCER CELL CULTURE; CHRYSANTHEMUM; COLON CARCINOMA; CRATAEGUS; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME INDUCTION; GENTIAN; GINGER; GRAPEFRUIT; HERBAL MEDICINE; HUMAN; HUMAN CELL; LINSEED; LONICERA; LYCIUM; PERNA; POLLEN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHODIOLA; SABAL; SALVIA OFFICINALIS; SCHISANDRACEAE; SOLIDAGO;

CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; DIETARY SUPPLEMENTS; DNA PRIMERS; HUMANS; P-GLYCOPROTEIN; PHYTOTHERAPY; PLANTS, MEDICINAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

ZINGIBER OFFICINALE;

EID: 33947585786     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2057     Document Type: Article

References (25)

1. Ahmed SM, Banner NR, Dubrey SW. 2001. Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients. J Heart Lung Transplant 20: 795.
2. Backlund M, Ingelman-Sundberg M. 2004. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. Mol Pharmacol 65: 416-425.
3. Black VH, Quattrochi LC. 2004. Molecular cloning of the guinea pig CYP1A2 gene 5′ flanking region: identification of functional aromatic hydrocarbon response element and characterization of CYP1A2 expression in GPC16 cells. Drug Metab Dispos 32: 595-602.
4. Brandon EFA, Bosch TM, Deenen MJ et al. 2006. Validation of in vitro models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphism in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. Toxicol Appl Pharmacol 211: 1-10.
5. Campbell ME, Grant DM, Inaba T, Kalow W. 1987. Biotransformation of caffeine, paraxanthine, theophylline and theobromine by polycyclic aromatic inducible cytochrome(s) P-450 in human liver microsomes. Drug Metab Dispos 15: 237-249.
6. Ekins S, Erickson JA. 2002. A pharmacophore for human pregnane X receptor ligands. Drug Metab Dispos 30: 96-99.
7. Engman HA, Lennernäs H, Taipalensuu J, Otter C, Leidvik B, Artursson P. 2001. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. J Pharm Sci 90: 1736-1751.
8. Geick A, Eichelbaum M, Burk O. 2001. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276: 14581-14587.
9. Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD. 2004. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 75: 89-100.
10. Handschin C, Meyer UA. 2003. Induction of drug metabolism: The role of nuclear receptors. Pharmacol Rev 55: 649-673.
11. Harper PA, Prokipcak RD, Bush LE, Golas CL, Okey AB. 1991. Detection and characterization of the Ah receptor in the human colon adenocarcinoma cell line LS180. Arch Biochem Biophys 290: 27-36.
12. Hartley DP, Dai X, He YD, Carlini EJ, Wang B, Huskey SE, Ulrich RG, Rushmore TH, Evers R, Evans DC. 2004. Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. Mol Pharmacol 65: 1159-1171.
13. Honkakoski P, Sueyoshi T, Negishi M. 2003. Drug-activated nuclear receptors CAR and PXR. Ann Med 35: 172-182.
14. McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tuckey RH. 1990. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450s. Cancer Res 50: 3367-3376.
15. Moore LM, Parks DJ, Jones SA et al. 2000. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275: 15122-15127.
16. Mu Y, Zhang J, Zhang S et al. 2006. Traditional Chinese medicines Wu Wei Zi (Shisandra Chinesis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate PXR and increase warfarin clearance in rats. J Pharmacol Exp Ther 316: 1369-1377.
17. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. 2004. Role of the aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279: 23847-23850.
18. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res 30: (9) e36.
19. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Fallon J. 2000. Indinavir concentrations and St. John's wort. Lancet 355: 547-548.
20. Prufunder A, Gutmann H, Beglinger C, Drewe J. 2003. Gene expression of CYP3A4, ABC- transporters (MDR1 and MRP1-5) and PXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 55: 59-66.
21. Ståhlberg A, Håkansson J, Xian X, Semb H, Kubista M. 2004. Properties of the reverse transcription reaction in mRNA quantification. Clin Chem 50: 509-515.
22. Vignati LA, Bogni A, Grossi P, Monshouwer M. 2004. A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction. Toxicology 199: 23-33.
23. Wang T, Brown MJ. 1999. mRNA quantification by real time TaqMan polymerase chain reaction: validation and comparison with RNase protection assay. Anal Biochem 269: 201.
24. Withlock Jr JP. 1999. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39: 103-125.
25. Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW. 2003. Interactions of herbs with cytochrome P450. Drug Metab Rev 35: 35-98.